Cloudbyz

JUNE 26, 2023

Generative artificial intelligence (AI) techniques are increasingly being applied in clinical research to enhance various aspects of medical data analysis, diagnosis, treatment planning, and drug discovery. These notes have been used to advance research in NLP and clinical decision support systems.

Clinical Research 78

Clinical Research Research Clinical Trials Clinical Trials 78

ACRP blog

JUNE 7, 2023

If you hadn’t already noticed, the clinical research enterprise has well and truly entered the era of “big data,” artificial intelligence (AI), and machine learning. Undoubtedly, the expectations for precision medicine are high,” Olsen adds.

Big Data 59

Big Data Clinical Research Research Clinical Trials 59

Scienmag

FEBRUARY 19, 2021

Anaylsis shows different genetic risk landscape for IBD In African Americans, the genetic risk landscape for inflammatory bowel disease (IBD) is very different from that of people with European ancestry, according to results of the first whole-genome study of IBD in African Americans.

Genome 50

Genome Genomics Genetics Clinical Research 50

Medical Xpress

DECEMBER 20, 2022

Southampton clinical researchers, working as part of a UK team, have shed new light on causes of bronchiectasis, a long-term lung condition currently effecting more than 200,000 people in the UK.

Genome 111

Genome Genomics Clinical Research Research 111

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. Essentially, the collaboration brought together both “the right expertise and the right technology”, opening up myriad possibilities for targeting GPCRs within the human genome.

Development 134

Development Research Drugs Clinical Trials 134

WCG Clinical

NOVEMBER 17, 2023

Originally released in 1976, the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules ( NIH Guidelines ) serve as the foundation of biosafety-focused oversight of research involving recombinant or synthetic nucleic acids (rsNA). Since then, however, certain genetic engineering technologies (e.g.,

Genome 52

Genome Genomics Gene Editing Genetic Engineering 52

Medical Xpress

NOVEMBER 21, 2022

In a new study published in Circulation: Genomics & Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting both long QT syndrome (LQTS) and short QT syndrome (SQTS).

Gene Therapy 67

Gene Therapy Gene Genome Genomics 67

XTalks

MAY 23, 2024

One of the more intriguing developments in cancer research in recent years is the growing understanding of clonal hematopoiesis, a phenomenon where blood cells expand from a single clone due to genetic mutations. Clonal hematopoiesis increases in prevalence with age and can precede hematologic malignancies.

Genetics 114

Genetics Research Genome Genomics 114

Medical Xpress

DECEMBER 29, 2022

A clinical research team from the University of Hong Kong (HKUMed) has used amniotic fluid cells obtained during 16-24 weeks of pregnancy as a novel sample type for RNA-sequencing in prenatal diagnosis to help more families with tailored clinical management.

RNA 75

RNA Genome Genomics Clinical Research 75

pharmaphorum

DECEMBER 21, 2021

In a recent webinar held by pharmaphorum, in partnership with IQVIA, a discussion was held looking at how to make academic and commercial medical research more efficient, while also looking at the opportunity of genomic data to bring benefits to patients and healthcare systems. The potential to leverage genomic data.

Development 98

Development Genome Genomics Drugs 98

Drug Discovery World

MAY 17, 2024

Deepika Khedekar , Associate Centralized Clinical Trial Lead at IQVIA Inc, looks at the challenges of utilising artificial intelligence (AI) in oncology clinical research. MIT research 4 tells us a hard truth: about 95% of these trials fall short, leaving behind a trail of broken hopes for cancer patients each year.

Trials 59

Trials Clinical Trials Clinical Trials Protein 59

XTalks

MAY 20, 2022

Do you possess laboratory skills, an analytical mindset and a penchant for research? If you enjoy working with biological samples and are enthusiastic about healthcare, a career as a clinical scientist might be just right for you. To start applying to clinical scientist jobs today, head over to the Xtalks Job Search platform.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

Drug Discovery World

APRIL 14, 2023

The American Association for Cancer Research (AACR) will honour the following cancer researchers, physician-scientists, advocates, and journalists during its annual meeting to be held April 14-19 at the Orange County Convention Center in Orlando, Florida. June’s award lecture will be held on Sunday April 16 at 4:30pm ET.

Genetics 52

Genetics Research Medicine Clinical Research 52

pharmaphorum

AUGUST 5, 2021

A recent clinical research paper highlights the importance of targeting of PPIs in stem cells of cancer. A PPI network was constructed from nine colon stem cell markers in order to identify potential genetic targets in patients. This innovative method now brings technology closer to developing genome-wide PPI networks.

Protein 125

Protein Gene Bioassay DNA 125

pharmaphorum

DECEMBER 20, 2022

The ICR and The Royal Marsden have embarked on an ambitious research collaboration to disrupt the cancer cell ecosystem. Oncology trial starts reached historic highs in 2021, and a record 30 oncology novel active substances were launched globally the same year, according to research by IQVIA. Attacking from all angles.

Scientist 98

Scientist Research Genetics Drugs 98

Drug Discovery World

OCTOBER 16, 2023

Here, DDW’s Megan Thomas highlights the research taking place and where this is happening. This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

SEPTEMBER 12, 2022

Alongside drugs and therapeutics, data collection and technology enhancements have redefined the traditional healthcare experience, especially within oncology, and genomic profiling has become a significant factor in allowing for personalised care. In other words, every person’s cancer has its own genetic construct. Tailored oncology.

Genome 104

Genome Genomics Clinical Trials Clinical Trials 104

XTalks

FEBRUARY 4, 2021

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Generation of strong research dataset cohorts must begin with high-quality clinical samples. Partnerships and Establishing Research Cohorts.

Research 98

Research Biobanking Drugs Genome 98

pharmaphorum

NOVEMBER 27, 2022

A group representing pharma companies selling precision therapies for cancer has called for a change to the way genomic testing is done in Scotland, to make sure patients get access to targeted drugs. “It would have saved me and the NHS a lot of money. . “It would have saved me and the NHS a lot of money. .” Why not lead?”

Genome 102

Genome Genomics Genetics Medicine 102

pharmaphorum

MAY 18, 2022

One research-driven company with a strong patient focus in neurology is UCB. “In In epilepsy research, for instance, a lot of progress has been made over recent years that has helped improve the lives of many people living with the disease. In everything we do, our guiding question is: What difference will this make for patients?”

Gene Therapy 92

Gene Therapy Gene Genetics Development 92

Drug Discovery World

SEPTEMBER 22, 2023

Researchers from the Francis Crick Institute, King’s College London and Guy’s and St Thomas’ NHS Foundation Trust in the UK have characterised a specialised type of immune cell, which plays a key role in protecting and repairing the cells in the healthy human gut.

Gene 52

Gene Development Research Clinical Research 52

Drug Discovery World

MAY 11, 2023

Researchers at Université de Montréal have discovered a way to potentially restore vision in patients suffering from degenerative retinal disease. Inherited retinal degenerations are caused by the loss of light-sensitive cells in the retina at the back of the eye.

Gene Therapy 52

Gene Therapy Gene Research Scientist 52

Roots Analysis

MARCH 24, 2022

Scientific fields involved in high throughput measurement of biological molecules are referred with the suffix- omics including, transcriptomics, genomics, proteomics and metabolomics. Genomics is the study of genetic material within a cell, and transcriptomics is the study of gene activity in different cells. Web: [link].

Clinical Research 52

Clinical Research Development Research Drug Delivery Systems 52

Advarra

NOVEMBER 29, 2022

The field of cell and gene therapies (CGT) is constantly evolving, and there has been significant progress in this area of research. However, despite the promise of these therapies, the regulations governing them lag the science, which in turn hinders the clinical translation of these novel medicines.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52

XTalks

APRIL 24, 2023

Approximately 72 percent of rare diseases are genetic, and around 70 percent of rare genetic diseases emerge in childhood. Watch the free, on-demand webinar and gain valuable insights from this team of clinical research experts. Rare diseases can often be progressive, chronic and fatal.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

XTalks

FEBRUARY 27, 2024

Rare Disease Day 2024, which falls on February 29 this year, is an opportunity to unite under a common cause: to bring attention to the challenges faced by those living with rare diseases and to push for advancements in research, treatment and policy. The FDA introduced its Orphan Drug Act in 1983.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

pharmaphorum

OCTOBER 7, 2021

The answer to the problem, of course, lays in making medical research more effective. However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. Far more common than initially thought, rare disease treatments remain far too scarce.

Genome 98

Genome Genomics Medicine Life Science 98

XTalks

NOVEMBER 7, 2022

These tumor-derived entities are used to derive genomic and proteomic data. The researchers concluded that the concentration of mutant fragments is correlated to the stage of the cancer and the type of cancer. Detection of Genomic Alterations from cfDNA: Targeted, Non-Personalized Approaches. cfDNA Isolation Techniques.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

Drug Discovery World

MAY 30, 2023

As the US National Cancer Research Month draws to a close, we asked experts from across the industry “What do you feel has been the most exciting development in cancer research in the last five years?” Here are their answers. This understanding of tumour diversity is driving a new approach to personalised therapy.

Research 52

Research Drugs Protein RNA 52

Drug Discovery World

AUGUST 10, 2022

But decades of research led to improvements in cancer therapy, centred around the idea that one’s immune system could aid in treatment. Since 2017, five CAR T cell therapies have been approved and have shown incredible success in the clinic. If the gene does not integrate into the genome, the cell will not become a CAR T cell.

Manufacturing 98

Manufacturing Gene Genome Genomics 98

XTalks

MARCH 25, 2021

From mergers and acquisitions to deep dives into new, emerging technologies, as well as the latest research findings and trends, the podcast will be an engaging new way to stay up to date with all the latest news in the life sciences. She has presented her research at international conferences and published several peer-reviewed papers.

Life Science 105

Life Science HR Clinical Trials Clinical Trials 105

The Pharma Data

OCTOBER 27, 2020

.” The single-reaction panel targets five regions of the viral genome and provides excellent accuracy and sensitivity. “Most real time qPCR-based assays target only two or three targets on the viral genome.” “Most real time qPCR-based assays target only two or three targets on the viral genome.”

Genetic Analysis 52

Genetic Analysis Genome Genomics Reagent 52

XTalks

SEPTEMBER 12, 2023

Biomedical Research and Technologies: Get access to the most recent biomedical research news from both industry and academia, including preclinical studies and technological breakthroughs in genomics, single cell analysis, proteomics, metabolomics and much more.

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

XTalks

DECEMBER 1, 2020

Over the past several years, personalized medicine has led the charge in medical innovation, leading drug development efforts as well as furthering the research community’s understanding of human disease states. With this has come an increase in the size of the global clinical trials market, with an estimated worth of around $46.8

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

pharmaphorum

SEPTEMBER 1, 2020

The war had also encouraged research into everything from new analgesics to drugs against typhus, with a great deal of collaboration between the companies and government. This knowledge of genetics and the underlying cause of many diseases, including cancer, has resulted in powerful new drugs. Post-war period.

Medicine 145

Medicine Insulin Pharmacy Drugs 145

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

The Pharma Data

JANUARY 10, 2021

Nasdaq: EDIT), a leading genome editing company, today announced the U.S. Food and Drug Administration (FDA) has cleared the initiation of the safety phase of the Company’s EDIT-301 clinical trial, and the Company can begin dosing patients. Clinical trial materials are being manufactured by Editas Medicine. CAMBRIDGE, Mass.,

Medicine 52

Medicine Development Clinical Trials Clinical Trials 52